Daniel P. Wermeling - Concepedia

Author

Daniel P. Wermeling

Also Known As

D P Wermeling, D WERMELING, D Wermeling, D. P. WERMELING, D. WERMELING, D. Wermeling, D.P. Wermeling, Daniel P Wermeling, Daniel P. Wermeling, Daniel P. Wermeling, PharmD

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

University of Kentucky Albert B. Chandler Hospital Translational Therapeutics (United States)Advanced Technologies Group (United States)Solvay (United States)

About

Daniel P. Wermeling is an author at University of Kentucky specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	1.1K
2	Health Sciences	8	8	206
3	Engineering	1	1	301
4	Humanities	1	1	12
5	Nursing	1	1	26

Daniel P. Wermeling

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Microneedles permit transdermal delivery of a skin-impermeant medication to humans Daniel P. Wermeling, Stan L. Banks, David A. Hudson, Proceedings of the National Academy of Sciences Tissue EngineeringNanomedicineCell-based Drug DeliveryTransdermal DeliveryEngineering	2008	301
Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis Jack D. Sobel, Doris Brooker, Gary E. Stein, American Journal of Obstetrics and Gynecology Antifungal AgentVaginitisTopical DrugAntimicrobial ChemotherapyDermatology	1995	151
Bioavailability and Pharmacokinetics of Lorazepam after Intranasal, Intravenous, and Intramuscular Administration Daniel P. Wermeling, Jodi L. Miller, Sanford M. Archer, The Journal of Clinical Pharmacology Intranasal AdministrationPharmacological StudyMedicineFavorable PharmacokineticsNeuropharmacology	2001	112
Naloxone for Opioid Overdose Prevention Abby M. Bailey, Daniel P. Wermeling Annals of Pharmacotherapy	2014	101
Pharmacokinetics and Pharmacodynamics of Intrathecal Ziconotide in Chronic Pain Patients Daniel P. Wermeling, Michael Drass, David Ellis, The Journal of Clinical Pharmacology	2003	89
A response to the opioid overdose epidemic: naloxone nasal spray Daniel P. Wermeling Drug Delivery and Translational Research Opioid EpidemicSubstance AbuseNaloxone Nasal SprayAddictionDrug Policy	2012	68
Pharmacokinetics and Pharmacodynamics of a New Intranasal Midazolam Formulation in Healthy Volunteers Daniel P. Wermeling, Kenneth A. Record, Thomas H. Kelly, Anesthesia & Analgesia Drug SafetyNovel IntranasalAllergyIv MidazolamPharmacological Study	2006	68
Pharmacokinetics, Pharmacodynamics, and Safety of Metrifonate in Patients with Alzheimer's Disease L. Creed Pettigrew, Florian Bieber, John Lettieri, The Journal of Clinical Pharmacology	1998	54
Hydromorphone Transfer into Breast Milk After Intranasal Administration Jeffrey E. Edwards, Anita Rudy, Daniel P. Wermeling, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2003	51
Pharmacokinetics and Bioavailability of Single-Dose Intranasal Hydromorphone Hydrochloride in Healthy Volunteers Barbara A. Coda, Anita Rudy, Sanford M. Archer, Anesthesia & Analgesia	2003	48

Page 1